Identify patients (12 years or older) with active infections who are receiving targeted antimicrobials as outlined below
Antimicrobials available in both IV and PO formulations AND the oral formulation has excellent (greater than 80%) oral bioavailability:
IV antimicrobials with oral analogues that attain lower AUC, and/or possess a slightly narrower spectrum of activity: